When Surveyors Dig Deeper: The Shift Toward Meaningful Diversion Programs

Our guest: Hossam Gamal, PharmD, BCPS, MBAWelcome to Drug Diversion Insights. In today's episode, we're diving into a critical conversation about hospital drug diversion programs and the evolving landscape of regulatory oversight. I'm joined by Dr. Hossam Gamal, an experienced Pharmacy Director who brings valuable insights into how surveyors are increasingly scrutinizing diversion mitigation efforts.Recent trends suggest a significant shift in how facilities are being evaluated - moving beyond simply checking boxes to requiring truly meaningful diversion programs. Dr. Gamal will share his firsthand experiences with recent surveys, discussing how regulators are examining program effectiveness, the role of monitoring software, and the essential components of a robust diversion response strategy.We'll explore whether surveyors are equipped with the necessary technical knowledge to evaluate these programs effectively, drawing parallels to similar challenges faced in other areas of healthcare compliance. Of particular interest is Dr. Gamal's perspective on establishing clear criteria for activating diversion response teams - a critical yet often overlooked aspect of comprehensive diversion mitigation.This conversation comes at a crucial time when healthcare facilities nationwide are reevaluating their approach to diversion mitigation. Whether you're a healthcare administrator, pharmacy professional, or compliance officer, today's discussion will provide valuable insights into creating and maintaining effective diversion programs that meet increasingly rigorous regulatory expectations.Thanks to our sponsor, MIDAS Healthcare SolutionsLearn more about V.I.E.W. Waste and Return System: https://midashs.com/products/For more information on Drug Diversion mitigation and resources, visit: https://www.rxpert.solutions/#drugdiversion #hospitalpharmacy #opioidcrisis #hospitalworker